Clinical Trial Update: Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the safety of giving whole-brain radiation therapy (WBR) at the same time as intrathecal liposomal cytarabine (DepoCyte) versus afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Leptomeningeal Metastasis

Drugs mentioned

• Depocyte

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Solid Tumour Neoplastic Meningitis, Brain Metastases | Phase 1 | Status: COMPLETED